novo nordisk glp 1 drugs Nordisk's weight-loss pill wins FDA approval Novo Nordisk launches its Wegovy
Description
10.1016/j.mce.2023.112013 59 ShaoY.-Q.WangY.-C.WangL.RuanH.-Z.LiuY.-F.ZhangT.-H.et al (2024)
GIP-GLP receptor co-agonists Alongside GLP-1, GIP is a primary incretin hormone that has shown neuroprotective properties in mouse models of PD and AD [98]
Individuals with Obesity or Overweight: Especially those with weight-related health problems like high blood pressure, high cholesterol, or sleep apnea
In the previous KFF poll, about half of all adults who took a GLP-1 drug said it was hard for them to afford it
They concluded that incretin-based medications did not correlate with an increased risk of acute pancreatitis or pancreatic cancer compared to other oral anti-diabetic agents, which remained consistent across drug classification and duration of use [29,55]
doi: 10.1111/j.1463-1326.2012.01676.x
